These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Abnormal platelet cytoskeletal assembly in hemodialyzed patients results in deficient tyrosine phosphorylation signaling. Díaz-Ricart M; Estebanell E; Cases A; Calls J; López-Pedret J; Carretero M; Castillo R; Ordinas A; Escolar G Kidney Int; 2000 May; 57(5):1905-14. PubMed ID: 10792609 [TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human erythropoietin treatment on circulating reticulated platelets in uremic patients: association with early improvement in platelet function. Tàssies D; Reverter JC; Cases A; Calls J; Escolar G; Ordinas A Am J Hematol; 1998 Oct; 59(2):105-9. PubMed ID: 9766793 [TBL] [Abstract][Full Text] [Related]
5. Plasma and platelet von Willebrand factor defects in uremia. Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111 [TBL] [Abstract][Full Text] [Related]
6. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors. Sreedhara R; Itagaki I; Hakim RM Am J Kidney Dis; 1996 Mar; 27(3):355-64. PubMed ID: 8604704 [TBL] [Abstract][Full Text] [Related]
7. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation. Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892 [TBL] [Abstract][Full Text] [Related]
8. Platelet aggregation and prostaglandin metabolism in uremic patients. Pietrzak I; Komarnicki M; Zaremba-Drobnik D Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S111-4. PubMed ID: 11576934 [TBL] [Abstract][Full Text] [Related]
9. Enhanced platelet apoptosis in chronic uremic patients. Li M; Wang Z; Ma T; Lu G; Yan R; Zhao L; Deng K; Dai K Ren Fail; 2014 Jul; 36(6):847-53. PubMed ID: 24655051 [TBL] [Abstract][Full Text] [Related]
10. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis. Salvati F; Liani M Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805 [TBL] [Abstract][Full Text] [Related]
11. Elevated plasma glycocalicin levels and decreased ristocetin-induced platelet agglutination in hemodialysis patients. Himmelfarb J; Nelson S; McMonagle E; Holbrook D; Benoit SE; Michelson AD; Ault K Am J Kidney Dis; 1998 Jul; 32(1):132-8. PubMed ID: 9669434 [TBL] [Abstract][Full Text] [Related]
12. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease. Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871 [TBL] [Abstract][Full Text] [Related]
13. Reduction of platelet glycoprotein Ib in uraemia. Sloand EM; Sloand JA; Prodouz K; Klein HG; Yu MW; Harvath L; Fricke W Br J Haematol; 1991 Mar; 77(3):375-81. PubMed ID: 2012763 [TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes. Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis]. Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852 [TBL] [Abstract][Full Text] [Related]
16. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia. Elshamaa MF; Elghoroury EA; Helmy A Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197 [TBL] [Abstract][Full Text] [Related]
17. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen. Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111 [TBL] [Abstract][Full Text] [Related]
18. Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis. Malyszko J; Malyszko JS; Mysliwiec M Perit Dial Int; 2001; 21(2):158-65. PubMed ID: 11330560 [TBL] [Abstract][Full Text] [Related]
19. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B Nephron; 1996; 72(2):135-44. PubMed ID: 8684516 [TBL] [Abstract][Full Text] [Related]
20. Platelets and platelet function in patients with chronic uremia on maintenance hemodialysis. Jørgensen KA; Ingeberg S Nephron; 1979; 23(5):233-6. PubMed ID: 481658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]